Are Anti-Obesity Meds our Forever Drugs?
Summary This white paper explores what happens after patients stop taking GLP-1 and GIP anti-obesity medications like semaglutide and tirzepatide—and how to prevent the all-too-common rebound of weight gain. While these drugs are highly effective at suppressing appetite and improving metabolic function, their benefits can fade once discontinued, making a Read more…